Ozurdex for Treatment of Recalcitrant Diabetic Macular Edema

This study is currently recruiting participants.
Verified January 2013 by Retina Macula Institute
Sponsor:
Collaborator:
Allergan
Information provided by (Responsible Party):
Ron P. Gallemore, Retina Macula Institute
ClinicalTrials.gov Identifier:
NCT01571232
First received: April 2, 2012
Last updated: January 13, 2013
Last verified: January 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2013
  Estimated Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)